Gut microbiome, probiotics, gut-brain axis, and digestive health
253 articles
A completed trial tested whether probiotic and prebiotic supplementation could reduce premature aging-related inflammation in people living with HIV.
Age-related shifts in intestinal T cell populations may silently erode gut barrier function, accelerating the chronic inflammation that drives aging diseases.
A new microbial gene atlas of infant nasopharyngeal swabs maps how cystic fibrosis and clinical interventions alter early respiratory microbiomes.
Candida albicans and Group B Streptococcus form a dangerous partnership in the vaginal tract, boosting bacterial virulence and antibiotic resistance.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
A newly identified microRNA disrupts Paneth cell function in aging intestines, exposing older patients to life-threatening gut complications.
A specific gut bacterium produces deoxycholic acid that hijacks tumor immunity, offering new targets for breast cancer treatment.
A stem cell intestine model screened 3,500 compounds and flagged glycyrrhizin from black licorice as a top anti-inflammatory candidate for IBD.
A precision nutrition trial finds liver insulin resistance responds to dietary fat changes via gut microbiota shifts, while muscle IR does not.
A common gut microbe has evolved new oxygen tolerance in industrialized populations — and it may be reshaping your microbiome's spatial architecture.
A Princeton study finds maternal helminth exposure reshapes the microbiome to produce a metabolite that shields offspring from respiratory viruses.
A comprehensive review reveals how probiotics, bacteriophages, and predatory bacteria can restore oral microbial balance and prevent systemic disease.
